The gut-brain axis as a therapeutic target in alcohol use disorder: dietary fiber, intestinal barrier integrity, and neuroinflammatory mechanisms underlying depression
This Perspective proposes that intestinal barrier dysfunction represents an actionable upstream mechanism linking alcohol-induced gut dysbiosis with neuroinflammation, depression, and relapse vulnerability, and highlights dietary fiber supplementation as a physiologically grounded, accessible nutritional strategy to enhance endogenous butyrate production, improve intestinal barrier integrity, and attenuate neuroinflammatory signaling.
Abstract
Alcohol use disorder is frequently accompanied by major depressive disorder, yet the biological mechanisms linking both conditions remain incompletely understood. Increasing evidence suggests that chronic alcohol consumption disrupts the gut-brain axis by damaging intestinal tight junctions and inducing gut dysbiosis characterized by depletion of short-chain fatty acid-producing bacteria. The resulting impairment of intestinal barrier integrity may facilitate the translocation of bacterial lipopolysaccharide, promoting peripheral and central neuroinflammation through Toll-like receptor 4-dependent pathways. These neuroinflammatory alterations may persist during abstinence and contribute to glutamatergic, dopaminergic, and serotonergic dysregulation associated with depressive symptoms and relapse vulnerability. This Perspective proposes that intestinal barrier dysfunction represents an actionable upstream mechanism linking alcohol-induced gut dysbiosis with neuroinflammation, depression, and relapse vulnerability, and highlights dietary fiber supplementation as a physiologically grounded, accessible nutritional strategy to enhance endogenous butyrate production, improve intestinal barrier integrity, and attenuate neuroinflammatory signaling. Available preclinical and clinical evidence is critically evaluated, and key priorities for future mechanistic and clinical studies are outlined.
Alcohol use disorder (AUD) is a chronic, relapsing neuropsychiatric disorder with limited treatment options. The gut-liver-brain axis has emerged as an important contributor to alcohol addiction. Within this axis, bile acids, important signaling molecules that connect the gut, liver, and central nervous system (CNS), h...
Xu-Mei Lin, Xiao-Jie Yu, Xue Bai et al.· Behavioural Brain Research· 0 citations
The microbiota-gut-brain axis represents a complex bidirectional communication network linking the intestinal microbiota with the central nervous system through neural, endocrine, immune, and metabolic pathways. Growing evidence suggests that alterations in gut microbiota composition may contribute to the pathophysiolo...
Agnieszka Kafara, Zuzanna Kafara, Julia Koronczok-Matusiak et al.· International Journal of Inn...· 0 citations
Depression is a major global public health challenge with limitations in current therapies. Emerging evidence highlights that gut microbiota (GM) critically regulates the gut-brain axis via tryptophan (Trp) metabolism. Trp is metabolized through host-directed serotonin (5-HT) and kynurenine (KYN) pathways, as well as m...
Hao-Yuan Tan, Yu-Xin Pang, Qiao-Yu Ji et al.· Frontiers in Microbiology· 0 citations
It is argued that microbiota‐targeted interventions, including probiotics, prebiotics, faecal microbiota transplantation (FMT) and dietary modulation, can alleviate METH‐induced affective disturbances, multiorgan damage, reproductive impairment and relapse risk, via restoring gut microbial homeostasis, repairing intest...
Alcohol use disorder (AUD) is a leading contributor to global morbidity and mortality, yet current treatments remain underutilized and only partially effective. Although AUD has traditionally been conceptualized as a brain-centered disorder, emerging evidence supports an integrative framework in which peripheral physio...
Taylor Lehner, D. Sandoval, Rebecca L. McCullough· Alcohol· 0 citations
Abstract Major depressive disorder (MDD) is a prevalent and disabling psychiatric condition. Its pathophysiology extends beyond monoamine deficiency to encompass systemic dysregulation of the gut-brain axis—a bidirectional network integrating neural, immune, endocrine, and microbial signals. Accumulating evidence indic...
Jing-Wen Zhang, Lin-Jing Wang, Shuai Shi et al.· Neuropsychiatric Disease and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.